Broderick J. M. FDA Approves Larotrectinib for NTRK + Cancers. OncLive, November 26, 2018. www.onclive.com/view/fda-approves-larotrectinib-for-ntrk-cancers
Darwin Ch. On the Origin of Species. Digireads.com. [Дарвин Ч. Происхождение видов путем естественного отбора, или Сохранение благоприятных рас в борьбе за жизнь. СПб.: Наука, 1991.]
Nowell P. C. The Clonal Evolution of Tumor Cell Populations. Science. 194, no. 4260 (1976): 23–28.
Greaves M., Maley C. C. Clonal Evolution in Cancer. Nature. 481 (2012): 306–313.
Janiszewska M. et al. Clonal Evolution in Cancer: A Tale of Twisted Twines. Cell Stem Cell. 16 (2015). doi:10.1016/j.stem.2014.12.011.
McGranahan N., Swanton Ch. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 168, no. 4 (2017): 613–628.
Fidler I. J. The Pathogenesis of Cancer Metastasis: The ‘Seed and Soil’ Hypothesis Revisited. Nature Reviews Cancer. 3 (2003): 453–458.
Ribatti D. et al. Stephen Paget and the ‘Seed and Soil’ Theory of Metastatic Dissemination. Clinical and Experimental Medicine. 6, no. 4 (2006): 145–149.
Fidler I. J. et al. The ‘Seed and Soil’ Hypothesis Revisited. Lancet Oncology. 9, no. 8 (2008): 808.
Pienta K. et al. The Cancer Diaspora: Metastasis Beyond the Seed and Soil Hypothesis. Clinical Cancer Research. 19, no. 21 (2013). doi:10.1158/1078–0432. CCR-13–2158.
Tiong Ing S. et al. New Drugs Creating New Challenges in Acute Myeloid Leukemia. Genes, Chromosomes & Cancer. (2019). doi:10.1002/gcc.22750.
Kubal T. E. et al. Safety and Feasibility of Outpatient Induction Chemotherapy with CPX-351 in Selected Older Adult Patients with Newly Diagnosed AML. Journal of Clinical Oncology. 36, supplement 15 (2018): e19013.
Levis M. Midostaurin Approved for FLT3-Mutated AML. Blood. 129 (2017): 3403–3406.
Глава 4. Китти СProfiles in Science. The Mary Lasker papers. US National Library of Medicine.
Wallace L. G. Catalyst for the National Cancer Act: Mary Lasker. Albert and Mary Lasker Foundation. December 15, 2016. https://laskerfoundation.org/catalyst-for-the-national-cancer-act-mary-lasker/
National Cancer Act of 1971. National Cancer Institute. https://dtp.cancer.gov/timeline/noflash/milestones/M4_Nixon.htm
Holford T. R. Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964–2012. JAMA. 311, no. 2 (2014): 164–171.
Kolata G. Advances Elusive in the Drive to Cure Cancer. New York Times, April 23, 2009.
Leaf C. The Truth in Small Doses: Why We’re Losing the War on Cancer – And How to Win. New York: Simon & Schuster, 2013.
Baker M. 1,500 Scientists Lift the Lid on Reproducibility: Survey Sheds Light on the ‘Crisis’ Rocking Research. Nature. 533 (2016): 452–454.
DeVita V. T., Jr., Chu E. A History of Cancer Chemotherapy. Cancer Research. 68, no. 21 (2008). doi:10.1158/0008–5472.CAN-07–6611.
Gilligan A. M. Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. American Journal of Medicine. 131, no. 10 (2018): 1187–1199.